BIOMAT Database Logo BIOMAT Database Logo

Structure-activity relationships of peptide T-related pentapeptides. 1989

M Marastoni, and S Salvadori, and G Balboni, and S Spisani, and R Gavioli, and S Traniello, and R Tomatis
Department of Pharmaceutical Sciences, University of Ferrara, Italy.

Fifteen pentapeptide analogs of C-terminal fragment of peptide T, H-Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-OH, were prepared and tested for human monocyte chemotaxis. Structure-activity studies suggest that the potent chemotactic activity of H-Thr-Thr-Asn-Tyr-Thr-OH is mediated through the polar properties of the C-terminal carboxyl group and Thr side chains at the critical positions 5 and 8, while the hydroxyl group of N-terminal Thr and its free amino function are not essential requirements for CD4 receptor interactions.

UI MeSH Term Description Entries
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D002627 Chemistry, Physical The study of CHEMICAL PHENOMENA and processes in terms of the underlying PHYSICAL PHENOMENA and processes. Physical Chemistry,Chemistries, Physical,Physical Chemistries
D002633 Chemotaxis The movement of cells or organisms toward or away from a substance in response to its concentration gradient. Haptotaxis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015704 CD4 Antigens 55-kDa antigens found on HELPER-INDUCER T-LYMPHOCYTES and on a variety of other immune cell types. They are members of the immunoglobulin supergene family and are implicated as associative recognition elements in MAJOR HISTOCOMPATIBILITY COMPLEX class II-restricted immune responses. On T-lymphocytes they define the helper/inducer subset. T4 antigens also serve as INTERLEUKIN-15 receptors and bind to the HIV receptors, binding directly to the HIV ENVELOPE PROTEIN GP120. Antigens, CD4,CD4 Molecule,CD4 Receptor,CD4 Receptors,Receptors, CD4,T4 Antigens, T-Cell,CD4 Antigen,Receptors, Surface CD4,Surface CD4 Receptor,Antigen, CD4,Antigens, T-Cell T4,CD4 Receptor, Surface,CD4 Receptors, Surface,Receptor, CD4,Surface CD4 Receptors,T-Cell T4 Antigens,T4 Antigens, T Cell
D015717 Peptide T N-(N-(N(2)-(N-(N-(N-(N-D-Alanyl L-seryl)-L-threonyl)-L-threonyl) L-threonyl)-L-asparaginyl)-L-tyrosyl) L-threonine. Octapeptide sharing sequence homology with HIV envelope protein gp120. It is potentially useful as antiviral agent in AIDS therapy. The core pentapeptide sequence, TTNYT, consisting of amino acids 4-8 in peptide T, is the HIV envelope sequence required for attachment to the CD4 receptor. HIV Peptide T,Peptide T, HIV
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

M Marastoni, and S Salvadori, and G Balboni, and S Spisani, and R Gavioli, and S Traniello, and R Tomatis
Structure-activity relationships for α-calcitonin gene-related peptide.
December 2013, British journal of pharmacology,
M Marastoni, and S Salvadori, and G Balboni, and S Spisani, and R Gavioli, and S Traniello, and R Tomatis
Peptide Bacteriocins--Structure Activity Relationships.
January 2015, Current topics in medicinal chemistry,
M Marastoni, and S Salvadori, and G Balboni, and S Spisani, and R Gavioli, and S Traniello, and R Tomatis
Structure-activity relationships of a snake cathelicidin-related peptide, BF-15.
December 2011, Peptides,
M Marastoni, and S Salvadori, and G Balboni, and S Spisani, and R Gavioli, and S Traniello, and R Tomatis
Designing Well-Structured Cyclic Pentapeptides Based on Sequence-Structure Relationships.
April 2018, The journal of physical chemistry. B,
M Marastoni, and S Salvadori, and G Balboni, and S Spisani, and R Gavioli, and S Traniello, and R Tomatis
Structure-activity relationships and structural conformation of a novel urotensin II-related peptide.
October 2004, Peptides,
M Marastoni, and S Salvadori, and G Balboni, and S Spisani, and R Gavioli, and S Traniello, and R Tomatis
Quantitative structure-activity relationships and docking studies of calcitonin gene-related peptide antagonists.
February 2012, Chemical biology & drug design,
M Marastoni, and S Salvadori, and G Balboni, and S Spisani, and R Gavioli, and S Traniello, and R Tomatis
Structure-activity relationships of a series of analogues of the RFamide-related peptide 26RFa.
July 2011, Journal of medicinal chemistry,
M Marastoni, and S Salvadori, and G Balboni, and S Spisani, and R Gavioli, and S Traniello, and R Tomatis
Peptide quantitative structure-activity relationships, a multivariate approach.
July 1987, Journal of medicinal chemistry,
M Marastoni, and S Salvadori, and G Balboni, and S Spisani, and R Gavioli, and S Traniello, and R Tomatis
Role of peptide structure in lipid-peptide interactions: a fluorescence study of the binding of pentagastrin-related pentapeptides to phospholipid vesicles.
December 1984, Biochemistry,
M Marastoni, and S Salvadori, and G Balboni, and S Spisani, and R Gavioli, and S Traniello, and R Tomatis
The prediction of bradykinin potentiating potency of pentapeptides. An example of a peptide quantitative structure-activity relationship.
February 1986, Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry,
Copied contents to your clipboard!